This topic contains 1 reply, has 2 voices, and was last updated by  J Howell 2 weeks, 1 day ago.

  • Author
  • #18502
     Ed Tobias 

    There are now 18 disease-modifying therapies approved for MS in the U.S. and close to that number in many other countries. Some are proving to be more effective than others, but they also carry a risk of more serious side effects. What’s your preference greater benefits and higher risk or lower benefit but less risk?

  • #18506
     J Howell 

    One week of Gilenya down…so far, so good, though I can’t say that I notice much difference other than some stomach upset (that frankly might be a lingering side effect of Solumedrol a couple of weeks ago) one way or the other.

    Hoping it will pump the brakes on new lesions and give my CNS some time without disease activity to recover. We’ll see.

You must be logged in to reply to this topic.

Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?


Create Account